Avadel Pharmaceuticals plc - AVDL
About Gravity Analytica
Recent News
- 09.16.2025 - Avadel Pharmaceuticals Celebrates Five Years of Driving Growth in Sleep Research Funding
- 09.16.2025 - Avadel Pharmaceuticals Celebrates Five Years of Driving Growth in Sleep Research Funding
- 09.10.2025 - Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- 09.10.2025 - Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- 09.10.2025 - H.C. Wainwright 27th Annual Global Investment Conference
- 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
- 09.05.2025 - 2025 Wells Fargo Healthcare Conference
- 09.05.2025 - Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension at World Sleep 2025
- 09.05.2025 - Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension at World Sleep 2025
- 09.03.2025 - Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd